The following article is from the February 25, 2026 issue of the journal Nature. I found it to be very interesting but one part was disappointing:
"Despite its promise, the therapy does not have a clear-cut path to the clinic, researchers say, because the US and European regulatory authorities do not consider frailty to be a disease."
3w6